O
PGNY icon

OrbiMed’s Progyny PGNY Stock Holding History

OrbiMed’s Portfolio PGNY Stock Details PGNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-259,900
Closed -$7.44M – 131
2024
Q2 		$7.44M Buy
259,900
+146,600
+129% +$4.41M 0.15% 82
2024
Q1 		$4.32M Buy
+113,300
New +$4.28M 0.08% 98
2023
Q2 		– Sell
-1,037,912
Closed -$33.3M – 132
2023
Q1 		$33.3M Buy
1,037,912
+2,912
+0.3% +$96.2K 0.65% 49
2022
Q4 		$32.2M Sell
1,035,000
-99,053
-9% -$3.58M 0.62% 56
2022
Q3 		$42K Buy
1,134,053
+509,053
+81% +$19.1M 0.78% 47
2022
Q2 		$18.2K Buy
+625,000
New +$22.4M 0.33% 66
2021
Q4 		– Sell
-1,270,045
Closed -$71.1M – 173
2021
Q3 		$71.1M Sell
1,270,045
-95,400
-7% -$5.27M 0.78% 40
2021
Q2 		$80.6M Sell
1,365,445
-559,815
-29% -$31.4M 0.81% 40
2021
Q1 		$85.7M Buy
1,925,260
+249,760
+15% +$11.7M 0.8% 37
2020
Q4 		$71M Hold
1,675,500
– – 0.62% 44
2020
Q3 		$49.3M Buy
1,675,500
+1,334,496
+391% +$36.8M 0.62% 48
2020
Q2 		$8.8M Buy
+341,004
New +$7.83M 0.12% 104

Other funds holding PGNY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

OrbiMed's PGNY Position: Q3 2024 in Review

OrbiMed sold out of Progyny (PGNY) in Q3 2024, closing a stake of 259,900 shares — an estimated $7.44M sold.

OrbiMed first reported a position in PGNY in Q2 2020 and held it in 12 quarters. The position peaked at $85.7M in Q1 2021. 285 funds tracked by Wall St. Rank hold PGNY as of Q3 2024.

  • OrbiMed reported no remaining Progyny position as of Q3 2024 after selling out during the quarter.
  • OrbiMed sold 259,900 Progyny shares in Q3 2024, an estimated $7.44M.
  • OrbiMed first reported a position in Progyny in Q2 2020 and held it in 12 quarters.
  • OrbiMed's Progyny position peaked at $85.7M in Q1 2021.
  • 285 funds tracked by Wall St. Rank held Progyny as of Q3 2024.

Based on OrbiMed's 13F filing for Q3 2024, filed 14 Nov 2024.